1 – 10 of 37
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Intratumoral T-cell and B-cell receptor architecture associates with distinct immune tumor microenvironment features and clinical outcomes of anti-PD-1/L1 immunotherapy
(
- Contribution to journal › Article
-
Mark
Mycoplasma pneumonia with severe cold agglutinin hemolysis, thrombocytosis, leukemoid reaction and acute renal failure
(
- Contribution to journal › Article
-
Mark
Reduced risk of serious pneumococcal infections up to 10 years after a dose of pneumococcal conjugate vaccine in established arthritis.
(
- Contribution to journal › Article
- 2022
-
Mark
Infection is associated with increased risk of MPO- but not PR3-ANCA associated vasculitis
(
- Contribution to journal › Article
- 2021
-
Mark
Methotrexate reduces circulating Th17 cells and impairs plasmablast and memory B cell expansions following pneumococcal conjugate immunization in RA patients
(
- Contribution to journal › Article
-
Mark
Incidence and predictors of severe infections in ANCA-associated vasculitis: a population-based cohort study.
(
- Contribution to journal › Article
-
Mark
Increased serum bactericidal activity of autologous serum in C2 deficiency after vaccination against Haemophilus influenzae type b, and further support for an MBL-dependent C2 bypass mechanism
(
- Contribution to journal › Article
- 2020
-
Mark
Infections are associated with increased risk of giant cell arteritis - a population-based case-control study from Southern Sweden
(
- Contribution to journal › Article
-
Mark
Incidence and predictors of severe infections in ANCA-associated vasculitis in a population-based cohort – preliminary results
(
- Contribution to journal › Published meeting abstract
-
Mark
Prime-boost vaccination strategy enhances immunogenicity compared to single pneumococcal conjugate vaccination in patients receiving conventional DMARDs, to some extent in abatacept but not in rituximab-treated patients
(
- Contribution to journal › Article